1. 1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial. (13th November 2020) Authors: Ledermann, J; Colombo, N; Oza, A; Fujiwara, K; Birrer, MJ; Randall, L; Poddubskaya, E; Scambia, G; Shparyk, YV; Lim, MC; Lim, MC; Sohn, J; Yonemori, K; Stewart, RA; Zhang, X; Perkins Smith, J; Linn, C; Monk, BJ Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 224OPatient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS). (24th November 2019) Authors: Friedlander, M L; Moore, K N; Colombo, N; Scambia, G; Kim, B-G; Oaknin, A; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, G S; Gourley, C; Banerjee, S; Oza, A; González-Martín, A; Aghajanian, C; Bradley, W; Lowe, E; Hettle, R; Flood, E; Disilvestro, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 263 Discordant mismatch repair protein expression in synchronous endometrial and ovarian cancers. (13th November 2020) Authors: Kim, S; Tone, A; Pollett, A; Kim, R; Cesari, M; Clarke, B; Eiriksson, L; Hart, T; Holter, S; Lytwyn, A; Maganti, M; Oldfield, L; Pugh, T; Gallinger, S; Bernardini, M; Oza, A; Dube, V; Lerner-Ellis, J; Van de Laar, E; Vicus, D Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 340 Performance characteristics of screening strategies to identify Lynch syndrome in women with non-serous and non-mucinous ovarian cancer. (13th November 2020) Authors: Kim, S; Tone, A; Pollett, A; Cesari, M; Clarke, B; Eiriksson, L; Hart, T; Holter, S; Lytwyn, A; Maganti, M; Oldfield, L; Pugh, T; Gallinger, S; Bernardini, M; Oza, A; Vicus, D; Dube, V; Kim, R; Ferguson, S Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3 Postprogression efficacy outcomes from the phase 3 ARIEL3 study of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma associated with either BRCA1 or BRCA2 mutations. (13th November 2020) Authors: Weberpals, J; Oza, A; Lorusso, D; Scambia, G; Aghajanian, C; Oaknin, A; Dean, A; Colombo, N; Clamp, AR; Leary, A; Holloway, RW; Amenedo Gancedo, M; Fong, PC; Goh, JC; O'Malley, DM; Armstrong, DK; Banerjee, S; García-Donas, J; Swisher, EM; Cameron, T Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 5 Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study. (13th November 2020) Authors: Kim, S; Tone, A; Pollett, A; Kim, R; Cesari, M; Clarke, B; Eiriksson, L; Hart, T; Holter, S; Lytwyn, A; Maganti, M; Oldfield, L; Pugh, T; Gallinger, S; Bernardini, M; Oza, A; Dube, V; Lerner-Ellis, J; Van de Laar, E; Vicus, D Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 944PQUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset. (23rd October 2018) Authors: Moore, K N; Secord, A A; Geller, M; Miller, D S; Cloven, N G; Fleming, G F; Wahner Hendrickson, A E; Azodi, M; DiSilvestro, P; Oza, A; Cristea, M; Berek, J S; Chan, J K; Rimel, B J; Li, Y; Luptakova, K; Clark, R; Matulonis, U A; Monk, B J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EP961 Are there opportunities to improve the number of women able to start and tolerate treatment for ovarian cancer? European perspectives from the world ovarian cancer coalition's every woman study. (1st November 2019) Authors: Reid, F; Oza, A; Bhatla, N; Blank, S; Cohen, R; Gardiner, D; Jones, A Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the Phase III SOLO1 trial. (1st November 2019) Authors: Moore, K; Colombo, N; Scambia, G; Kim, B-G; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; González-Martín, A; Aghajanian, C; Bradley, W; Mathews, C; Liu, J; Lowe, ES; Bloomfield, R Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P09 FIGO 2018 stage IB2 (≥2 to <4 cm) cervical cancer treated with neoadjuvant chemotherapy followed by fertility sparing surgery (CoNteSSa)/Neoadjuvant chemotherapy and conservative surgery in cervical cancer to preserve fertility (NeoCon-F). (1st November 2019) Authors: Plante, M; van Trommel, N; Lheureux, S; Oza, A; Wang, L; Sikorska, K; Ferguson, S; Han, K; Amant, F Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗